Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Heart Failure × Perindopril × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Heart Failure 1 Cardiotoxicity 1 Breast Neoplasms 1

Interventions

sacubitril and valsartan sodium hydrate drug combination 1 Valsartan 1 Perindopril 1 Bisoprolol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01016886 2016-02-09

MANTICORE

AHS Cancer Control Alberta

Phase 1/2 Unknown

Breast Neoplasms, Heart Failure, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡